About Nirrin Technologies
Nirrin Technologies is a Healthcare company based in Billerica (United States) founded in 2018 by Bryan Hassell. It operates as a developer of sensor and integration technologies for continuous control and bioprocess automation. Nirrin Technologies has raised $21.23 million across 4 funding rounds from investors including Gamma Biosciences. The company has 17 employees. Its chief executive is Jonathan Hartmann. Nirrin Technologies offers products and services including Atlas. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioreactors. Its legal entity is NIRRIN TECHNOLOGIES, INC. Its competitors include Unibio, Univercells Tech, Pow.Bio, Caladan Bio and BiOZEEN and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Founded in 2018, Nirrin Technologies operates in the biotechnology sector, focusing on sensor and integration solutions for continuous bioprocess control. Products such as the CellStat system, RTA-2300, RTA-1550, and RTA-2300 Perfusion are offered, along with bioLogYx software for digital and analog communications. The company is based in Billerica, United States, supporting automation in bioprocessing applications.
- Headquarters Billerica, United States
- Employees 17
- Founders Bryan Hassell
- SectorsHealthcare
- Email••••••••
- Website nirrin.tech
- Social LinkedIn
- Legal Name Nirrin Technologies, Inc
- Total Equity Funding$21.23M (USD)
in 4 rounds
- Latest Funding Round$9.71M (USD), Series A
Jul 2026
- Investors
- Employee Count17
Products & Services of Nirrin Technologies
Nirrin Technologies offers a comprehensive portfolio of products and services, including Atlas.
Provides rapid real-time monitoring for bioprocess with less sample and cost.
Funding Insights of Nirrin Technologies
Nirrin Technologies has successfully raised a total of $21.23M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $9.71 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21.23M
- Total Rounds 4
- Last Round Series A — $9.71M
- Investors Count 1
All 4 funding rounds of Nirrin Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2026 | $9.71M | Series A | – | – | – |
| Sep 2025 | $6.7M | Series A | – | – | – |
| Feb 2024 | $4.82M | Series A | – | – | – |
| Sep 2021 | – | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Nirrin Technologies
Nirrin Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gamma Biosciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A life sciences tools platform is operated by Gamma Biosciences. | 2019 | gammabiosciences.com | Menlo Park, United States |
Investor details for Nirrin Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nirrin Technologies
11 people are tracked at Nirrin Technologies (4 in leadership, 3 in board & advisors, 4 in team); the tracked headcount is 17.
| Name | Role | Group |
|---|---|---|
Bryan Hassell | Co-Founder | Leadership |
Jonathan Hartmann | CEO | Leadership |
Greg Phelps | Director Of Research And Development | Leadership |
Andrew Rodriguez | General Manager | Leadership |
David Michael | Chairman | Board & advisors |
John Ho | Co-founder & Board Member | Board & advisors |
David Seldin | Board Member | Board & advisors |
Denise McHugh | Office Manager | Team |
Justin Finn | Software Development Manager | Team |
David Marchessault | Mechanical Engineering Manager | Team |
Raymond Russell | Mechanical Engineer | Team |
Complete people profiles for Nirrin Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nirrin Technologies
3 dated milestones of Nirrin Technologies across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Nirrin Technologies is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $9.7M.
Competitors of Nirrin Technologies
Nirrin Technologies has 8 listed competitors in our database, 4 of them funded. They include Unibio, Univercells Tech, Pow.Bio, Caladan Bio and BiOZEEN, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unibio.dk | 2001 | Odense, Denmark | $30M | 59 | Animal feed supplements are produced using proprietary fermentation technology. | |
| univercellstech.com | 2020 | Nivelles, Belgium | – | 74 | Intensified biomanufacturing technologies for viral production are developed and manufactured. | |
| pow.bio | 2019 | Berkeley, United States | $9.5M | – | Intelligent fermentation services for industrial and synthetic biology are provided. | |
| caladan.bio | 2023 | Brooklyn, United States | $5.11M | – | Modular bioreactors are developed for biotechnology research applications. | |
| biozeen.com | 2005 | Bengaluru, India | – | 194 | Customized bioprocess equipment and automation solutions are provided for biopharmaceuticals. | |
| dab.bio | 2012 | Delft, Netherlands | $2.23M | – | Technology solutions for accelerated fermentation of renewable feedstocks are provided. | |
| brightpathlabs.com | 2019 | Santa Fe, United States | – | – | Spinning tube-in-tube continuous-flow reactors are developed for drug manufacturing. | |
| tecnic.eu | 2011 | Girona, Spain | – | – | Bioprocess equipment is developed for cell culture and microbial applications. |
Detailed competitors of Nirrin Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Nirrin Technologies
The website of Nirrin Technologies (nirrin.tech) receives about 2.1K visits a month.
- Monthly visits2.1K
▼ 13.7% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Nirrin Technologies (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nirrin Technologies
Complete news archive for Nirrin Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirrin Technologies
Nirrin Technologies was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Nirrin Technologies is headquartered in Billerica, United States. It is registered at Billerica, Massachusetts, United States.
Jonathan Hartmann is the current CEO of Nirrin Technologies.
Nirrin Technologies is a funded company, having raised a total of $21.23M across 4 funding rounds to date.
Nirrin Technologies has 17 employees.
Founded in 2018, Nirrin Technologies operates in the biotechnology sector, focusing on sensor and integration solutions for continuous bioprocess control. Products such as the CellStat system, RTA-2300, RTA-1550, and RTA-2300 Perfusion are offered, along with bioLogYx software for digital and analog communications. The company is based in Billerica, United States, supporting automation in bioprocessing applications.
Nirrin Technologies's top competitors include Unibio, Univercells Tech and Pow.Bio.
Nirrin Technologies offers Atlas.
Nirrin Technologies has 1 investor. Key investors include Gamma Biosciences.
Nirrin Technologies operates through Nirrin Technologies, Inc.